Growth Differentiation Factor-15 (GDF-15) a Precursory Biomarker for Diabetic Patients with Coronary Artery and Chronic Kidney Disease
Journal Title: International Journal of Diabetology & Vascular Disease Research (IJDVR) - Year 2017, Vol 5, Issue 4
Abstract
Background: Growth-differentiation factor-15 (GDF-15) is emerging as an important biomarker, thus the current study aimed to determine the levels of GDF-15 among, T2DM subjects with chronic kidney disease (CKD) and coronary artery disease (CAD). Methodology: The present cross sectional study comprised of 80 T2DM subjects with mean age of 60.15 ± 1.8 years. The study subjects were divided into four groups Group-I: T2DM subjects (T2DM), Group-II: T2DM subjects with chronic kidney disease (CKD), Group-III: T2DM subjects with established coronary artery disease (CAD) and Group-IV: T2DM subjects with CKD and established CAD. Anthropometric, demographic and biochemical parameters were measured in all study subjects. The levels of GDF-15 were measured in plasma using ELISA. Results: The level of GDF-15 was significantly higher in diabetic subjects having both CAD and CKD when compared to other study groups and significant difference was observed between the study groups (p<0.0001). Comparisons of GDF-15 levels between group’s shows statistical significance among the group I vs. other groups (p <0.0001), similar scenario were observed in group II vs. III (p< 0.05), IV (p <0.0001) and group III vs. IV (p< 0.05). There is a positive correlation with the level GDF-15 with duration of diabetes, systolic blood pressure, HbA1c, Urea, Creatinine and Triglyceride. Negative correlation were observed in eGFR (r = - 0.35, p < 0.001) and HDL (r = - 0.25 p = 0.03). Conclusion: The levels of GDF-15 are markedly increased in diabetic subjects having both CAD and CKD. The study finding highlights the major role of GDF-15 as a promising biomarker of CAD and CKD in T2DM subjects.
Authors and Affiliations
Vijay Viswanathan
Keywords
Related Articles
- EP ID EP325053
- DOI 10.19070/2328-353X-1700041
- Views 89
- Downloads 0
Application of Premixed Insulin NovoMix®30 and NovoRapid® as Multiple Daily Injections or as Basal Bolus Format in Selected Diabetic Patients: Practical Evidence from Prospective Case Series
Application of Premixed Insulin NovoMix®30 and NovoRapid® as Multiple Daily Injections or as Basal Bolus Format in Selected Diabetic Patients: Practical Evidence from Prospective Case Series
An Increase of Maximal Intima-Media Thickness in Bilateral Carotid Arteries Strongly Suggests the Existence of Coronary Stenosis in Japanese Type 2 Diabetic Patients
An association of an increase of maximal intima-media thickness (IMT) of carotid artery to coronary artery stenosis was evaluated in Japanese type 2 diabetic (T2DM) out-patients without any typical cardiac symptoms or hi...
The Diabetic Foot Syndrome an Ignored and Potential Problem in Medical Practice
The Diabetic Foot Syndrome an Ignored and Potential Problem in Medical Practice
Diabetic Peripheral Neuropathy: A Scoop
Diabetic Peripheral Neuropathy: A Scoop
The Attitudes about Complex Therapy Scale (ACTS) in Type 2 Diabetes and Cardiovascular Disease: Development, Validity and Reliability
Background: Type 2 diabetes is associated with cardiovascular disease, and patients with both conditions are prescribed complex medication regimens. Aim: The aim was to develop a reliable and valid measure of attitudes a...